Assignee
REMIX THERAPEUTICS INC
US·0 granted patents·25 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
25 records- 0162US2024226098A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0262US2026062699A1Methods and compositions for modulating splicing at alternative splice sitesREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0362US2024190879A1Fused bicyclic compounds useful for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0462US2023365566A1Heterocyclic amides and their use for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0559US2025082633A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0659US2023365526A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0759US2023140983A1Pyridazine derivatives for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0859US2025326748A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0959US2025092065A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1058US2024287097A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1158US2023159496A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1258US2024366612A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1358US2024279239A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1458US2025332173A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1557US2024400584A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1657US2024409536A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1757US2024368163A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1857US2025333397A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1957US2025154169A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2057US2023167093A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2152US2024239811A15-(5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the tREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2252US2024002375A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2352US2024018522A1Oligonucleotides useful for modulation of splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2449US2023148184A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2548US2023142338A1Thiophenyl derivatives useful for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →